Jump to Contents
Japan Institute for Health Security
Infectious Desease Information
Language switch 日本語

Toppage > Surveillance > IASR Vol.42, No.8(No.498) August 2021 Vancomycin-resistant enterococcus (VRE) infection in Japan

IASR Vol.42, No.8(No.498) August 2021 Vancomycin-resistant enterococcus (VRE) infection in Japan

Published: 26 December 2024
PDFdownload(PDF:449.56KB)

Vancomycin-resistant enterococcus (VRE) infection in Japan

  • Drug resistance mechanisms of vancomycin-resistant enterococci (VRE)
  • Overview of vancomycin-resistant enterococci (VRE) testing at the Osaka Institute of Public Health
  • Screening methods employed for vancomycin-resistant enterococci (VRE) during an outbreak
  • Vancomycin-resistant enterococci (VRE) outbreak in a cancer hospital in 2021
  • Clinical manifestations and treatment of vancomycin-resistant enterococci (VRE)
  • Detection and emergence of new epidemic strains of vancomycin-resistant enterococci (VRE) overseas
  • Increase in vancomycin-resistant enterococci (VRE) among livestock and possible transmission to humans via imported meat
  • Active epidemiological investigation of COVID-19 cases diagnosed after COVID-19 vaccination (first report), April- June 2021
  • Food poisoning outbreak due to norovirus G2.17 [P17] at multiple restaurants that employed the same food handler, Tokyo, February 2021
  • Epidemiological analysis of COVID-19 symptoms, Kanagawa Prefecture, April-May 2020
  • Analysis of replacement of SARS-CoV-2 strains with a variant carrying the N501Y mutation in Japan

Software may be required to view PDF, Word, Excel, and other files.
Please check “How to view files.” for details.